With antigen testing, the U.S. could have been well on its way toward crushing the pandemic by now.
About 40 percent of infected persons show no symptoms but may still transmit disease.
Cases per 1,000 tests are rising in the majority of states.
Cheap, rapid antigen tests may be on the way—and the FDA has finally approved test pooling.
Enable people to act responsibly toward their neighbors and co-workers.
If the findings are true, that's really great news.
It could quickly amplify coronavirus testing by tenfold.
Making cheap tests widely available would go a long way toward crushing the pandemic.
Cheap accurate testing would enable the safe reopening of the U.S. economy.
Also included is an "alternative facts" narrative of federal government testing screw-ups since January.
This proposal might work, but it's doubtful that our politicians and president are competent enough to pull it off.
Why not let recovered coronavirus patients out of lockdown?
The companies are complying. Customers won't get their results and are being told to destroy their test kits.
No time to waste; do it sooner rather than later.
Private-sector efforts to fill the testing vacuum run afoul of bureaucracy.
And it's not too late.
In two weeks we will know if his public health measures are too little, too late.
FDA and CDC bureaucrats stopped private and academic diagnostic tests from being deployed.
Did the Trump Administration Overpromise 1 Million COVID-19 Diagnostic Tests by the End of This Week?
The FDA has finally approved commercial diagnostic tests.
The promise of technical end-runs around government ineptitude